Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Poly Medicure Ltd Stock Analysis

Mid Cap
Evaluated by 1195 users | BSE: 531768 | NSE: POLYMED |
Medical Equipment/Supplies/Accessories

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Poly Medicure Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Capital Employed 24.92%24.47%26.84%25.13%21.2%17.81%16.54%17.07%14.14%17.19%15.41%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 170209252312374394440508587646747811
Y-o-Y Gr. Rt.-23.1%20.7%23.8%19.7%5.6%11.4%15.7%15.4%10.1%15.7%-
Adjusted EPS (Rs.) 2.592.963.984.544.954.995.617.136.919.6312.915.02
Y-o-Y Gr. Rt.-14.3%34.5%14.1%9%0.8%12.4%27.1%-3.1%39.4%34%-
Book Value per Share (Rs.) 8.8310.5412.5716.3321.7625.3730.4837.8743.0148.6399.42104.70
Adjusted Net Profit 22.826.135.14043.74449.562.960.985124144
Net Op. Cash Flow (Rs. Cr.) 21.832.838.365.363.361.95575.5113127116-
Debt to Cash Flow from Ops 1.891.41.271.031.21.281.761.691.331.491.05-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Poly Medicure Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales 15.2%13.6%13.7%15.7%
Adjusted EPS 17.8%20.9%21.9%34%
Book Value per Share 28.331.438104.4
Share Price 40.7% 40.3% 61.5% 107.4%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity (%) 33.1430.5734.4231.3625.9721.1720.0720.8317.062117.8814.72
Operating Profit Margin (%) 22.8926.727.0325.5322.6421.9121.4123.922.8425.1128.1526.34
Net Profit Margin (%) 13.4412.4913.9112.8211.6811.1611.2612.3710.3913.1516.5417.75
Debt to Equity 0.530.50.440.470.40.350.360.380.40.440.130.05
Working Capital Days 135136137132136144146157159173183329
Cash Conversion Cycle 6255565254677580817879238
Loading price chart...
Entity Percentage Holding
Promoters 44.77%
Institutions 16.55%
Non-Institutions 38.68%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Past 10 year's financial track record analysis by Moneyworkds4me indicates that Poly Medicure Ltd is a average quality company.

Poly Medicure Ltd's earnings have grown by 20.9%, whereas share price has appreciated 40.3% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

Poly Medicure Ltd share price has appreciated 40.7% annually (CAGR) over the past ten years.

Past 10 years financial track record analysis and assessment of future prospects by Moneyworks4me indicates that Poly Medicure Ltd is an average long term investment. However, you need to ensure you buy at a right price to earn good returns.

Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products.

POLYMED manufactures its products using state

Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products.

POLYMED manufactures its products using state of the art technology in ultra modern facilities covering over 300,000 square feet of manufacturing floor space with about 50,000 square feet of clean rooms of class 100,000 to class 1,000. A tool room with modern facilities & CNC machines supports the manufacturing processes. A high degree of automation and an effective process control helps in delivering consistent product quality.

To keep pace with the ever changing requirements of the market, POLYMED has a fully staffed and highly equipped R & D section to design and develop new and innovative products. Using the latest CAD/CAM technology, the new product development is fast and improvements, based on market response and customer feedback, are made with ease. Assuring world class products at affordable prices is the hall mark of POLYMED

Product range of the company:

The company manufactures different products related to :

  • Infusion Therapy
  • Central Venous Access Catheters
  • Anaesthesia
  • Urology
  • Gastroenterology
  • Blood Management
  • Surgery & Wound Drainage
  • Dialysis
  • Others

Achievements/ recognition:

  • QMS (Quality Management System) accredited by SGS
  • ISO 9001:2000
  • ISO-13485:2003
  • CE mark from DNV
  • US FDA 510k approved  
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback